Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-10-03
DOI
10.1111/all.14611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled Corticosteroid Therapy in Adult Asthma: Time for a New Therapeutic Dose Terminology
- (2019) Richard Beasley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
- (2019) Audrey Le Floc’h et al. ALLERGY
- Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
- (2018) William W. Busse et al. ADVANCES IN THERAPY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma
- (2018) Marek Lommatzsch et al. THORAX
- Commonality of the IL-4/IL-13 pathway in atopic diseases
- (2017) Namita A. Gandhi et al. Expert Review of Clinical Immunology
- Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
- (2017) Marjan Kerkhof et al. THORAX
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
- (2016) Jonathan Corren et al. CHEST
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Refractory asthma: mechanisms, targets, and therapy
- (2014) J. L. Trevor et al. ALLERGY
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
- (2014) L. E. Macdonald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe asthma: from characteristics to phenotypes to endotypes
- (2012) S. Wenzel CLINICAL AND EXPERIMENTAL ALLERGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Factors Associated With the Control of Severe Asthma
- (2010) Juan Luis Rodriguez Hermosa et al. JOURNAL OF ASTHMA
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
- (2008) J. Bousquet et al. ALLERGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search